Evidence map›Paper›PMID 30919055›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2019

Exploratory radiomic features from integrated

Serena Baiocco, Bert-Ram Sah, Andrew Mallia, Christian Kelly-Morland, Radhouene Neji, J James Stirling, Sami Jeljeli, Alessandro Bevilacqua, Gary J R Cook, Vicky Goh

Open access · hybridAbstract read
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Value ofFrontiers in oncology · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Serena BaioccoDepartment of Cancer Imaging, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Bert-Ram SahDepartment of Cancer Imaging, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Andrew MalliaDepartment of Cancer Imaging, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Christian Kelly-MorlandDepartment of Cancer Imaging, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Radhouene NejiMR Research Collaborations, Siemens Healthcare, Frimley, UK.
J James StirlingKing's College London & Guy's and St Thomas' PET Centre, St Thomas' Hospital, London, UK.
Sami JeljeliKing's College London & Guy's and St Thomas' PET Centre, St Thomas' Hospital, London, UK.
Alessandro BevilacquaAdvanced Research Center for Electronic Systems (ARCES), University of Bologna, Bologna, Italy.
Gary J R CookDepartment of Cancer Imaging, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Vicky GohDepartment of Cancer Imaging, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK. vicky.goh@kcl.ac.uk.ORCID http://orcid.org/0000-0002-2321-8091
St Thomas' Hospital · GBKing's College London · GBSiemens (United Kingdom) · GBUniversity of Bologna · IT

Funding

Cancer Research UK 16463Cancer Research UK C1519/A16463Wellcome Trust WT203148/Z/16/Z
6 · The paper itself

Abstract

purposeThe purpose of this study was to determine if

methodsFollowing IRB approval and informed consent, patients underwent a staging PET/MRI following

resultsTwenty patients (18 males, 2 female; median 67 years, range 52-86) comprised the final study cohort; ten patients had metastases. Lower second-order SUV entropy combined with higher second-order ADC entropy were the best feature-pair for discriminating metastatic patients, MANOVA p value <0.001 (SN = 80%, SP = 80%, PPV = 80%, NPV = 80%, ACC = 80%). SUV

conclusionHigh ADC entropy combined with low SUV entropy is associated with a higher prevalence of metastases and a promising initial signature for future study.

Indexed as

Magnetic Resonance ImagingPositron-Emission TomographyAgedAged, 80 and overAlgorithmsCluster AnalysisEsophageal NeoplasmsFemaleFluorodeoxyglucose F18Gastrointestinal NeoplasmsHumansImage Processing, Computer-AssistedMaleMiddle AgedMultimodal ImagingMultivariate AnalysisFluorodeoxyglucose F18Radiopharmaceuticals18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imagingOesophageal cancerRadiomic analysis

Identifiers

PMID30919055
PMCPMC6533412
OpenAlexW2924446121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.